U.S. Communications Stock News

If you are wondering whether JD.com at around US$27.73 is a bargain or a value trap, this article will walk you through what the current price might be implying about the stock. JD.com has recently seen an 8.2% gain over the last 7 days, although returns are still around 1.2% lower over 30 days and about 6.1% lower year to date, with a roughly 30.0% decline over 1 year and 64.4% over 5 years. Recent headlines have focused on JD.com as investors reassess large Chinese e commerce platforms,...

Kratos Defense & Security Solutions (NasdaqGS:KTOS) is exploring a partnership with Taiwan’s National Chung-Shan Institute of Science and Technology on autonomous "loyal wingman" drones built around its XQ-58A platform. The potential collaboration aims to integrate Kratos unmanned aerial technology into Taiwan’s local defense ecosystem and could support future production in the region. Separately, the Mighty Hornet IV loitering munition has completed operational validation, with local...

Cloudflare recently reported quarterly results featuring revenue of US$614.51 million and nearly 50% growth in new annual contract value, while also filing a US$3.63 billion shelf registration for ESOP-related Class A common stock and presenting at a major state and local cybersecurity summit in Washington, D.C. An eye-catching detail was management’s emphasis that AI agent requests more than doubled across Cloudflare’s network in January, underscoring its role as core infrastructure for...

If you are looking at Leidos Holdings and wondering whether the current share price reflects its true worth, you are not alone. The stock last closed at US$172.51, with returns of 29.9% over 1 year, 91.0% over 3 years, 93.8% over 5 years, and more recent moves of a 4.5% decline over 7 days and a 10.6% decline over 30 days hinting at shifting sentiment. These recent pullbacks have come after a period where Leidos has been gaining attention in the defense and government services space, which...

Why Electronic Arts is on investors’ radar today Electronic Arts (EA) is back on many watchlists after recent trading, with the stock last closing at $200.07. You might be weighing how its recent returns and fundamentals line up today. See our latest analysis for Electronic Arts. Recent trading has been fairly muted, with a 1 day share price return of 0.40% and a year to date share price return decline of 2.12%, while the 1 year total shareholder return of 45.73% points to stronger momentum...

In early March 2026, WesBanco, Inc. moved to shrink its board from 19 to 15 directors through a voluntary retirement program and class rebalancing, while also filing an omnibus shelf registration covering common and preferred stock, debt securities, warrants, purchase contracts, units, and depositary shares. These governance changes, paired with the flexibility to issue a wide range of securities, could influence how WesBanco manages its capital structure and aligns board oversight with peer...

If you are wondering whether Lockheed Martin's current share price still offers value after a strong run, you are not alone. The stock last closed at US$651.22, with returns of 4.4% over 30 days and 31.0% year to date, and a 42.7% return over the past year that may have shifted how some investors think about its risk and return profile. Recent news around Lockheed Martin has focused on its role as a major U.S. defense contractor in an environment where defense and security remain key...

If you are wondering whether American Express is still priced sensibly after its long run, or if you would be overpaying at today's level, this article focuses squarely on what you are getting for the price. The stock recently closed at US$303.15, with returns of a 1.5% decline over 7 days, a 15.6% decline over 30 days and an 18.7% decline year to date, while the 1 year and 3 year returns sit at 20.0% and 91.7%, and the 5 year return is 124.7%. Recent market commentary around American...

If you are wondering whether Lumexa Imaging Holdings is attractively priced or not, you are in the right place. This article will walk you through what the current market price might be implying about its value. The share price recently closed at US$14.45, with a 30 day return of 33.8%, a 7 day return reflecting a 6.6% decline, and a year to date return showing a 17.7% decline. These changes can influence how investors think about both upside potential and risk. Recent news around Lumexa...

Vistance Networks (VISN) is back in focus after reporting fourth quarter and full year 2025 results that shifted prior losses into net income and after showcasing a high profile Wi Fi 7 deployment at BMO Stadium. See our latest analysis for Vistance Networks. The recent move into profitability and the high profile Wi Fi 7 rollout have arrived during a softer period for the shares, with a 30 day share price return of a 7.11% decline and a 90 day share price return of a 12.36% decline. However,...

Casey’s General Stores (CASY) has put up another detailed scorecard for Q3 2026, with revenue of US$3.9 billion, basic EPS of US$3.51 and net income of US$130.1 million, while same store sales growth landed at 0.4%. The company has seen quarterly revenue move between US$3.9 billion and US$4.6 billion over the last few periods, with EPS ranging from US$2.35 to US$5.80 and trailing twelve month EPS at US$17.52 alongside net income of US$650.1 million. This sets the stage for investors to focus...

Event context and recent share performance Dropbox (DBX) has drawn investor attention recently as its shares show mixed returns, with a gain over the past month but declines over the past 3 months and year to date. See our latest analysis for Dropbox. At a share price of US$26.40, Dropbox’s recent 30 day share price return of 5.6% contrasts with a 90 day share price decline of 2.9%. Its 3 year total shareholder return of 35.0% suggests momentum has built more over the longer term than in the...

Royalty Pharma plc has appointed Kenneth Sun as Senior Vice President and Head of Asia, effective May 2026, to lead its royalty business from Hong Kong after his prior role heading Asia Pacific Healthcare Investment Banking at Morgan Stanley. This hire positions Royalty Pharma to pursue royalty opportunities tied to Asia’s expanding biotechnology and licensing activity, including the very large 2025 Chinese medicine out‑licensing market, by building a dedicated regional platform. We will now...

In late February 2026, Golar LNG Limited reported fourth-quarter 2025 revenue of US$132.81 million and net income of US$10.36 million, alongside full-year 2025 revenue of US$393.52 million and net income of US$65.68 million, declared a US$0.25 per share dividend payable in March 2026, and confirmed completion of a share buyback totaling 4,675,710 shares for US$117.32 million. Together, the stronger year-on-year financial results, cash return through dividends, and reduced share count from...

If you are wondering whether Affirm Holdings at around US$49.77 still offers value or if the big move is already behind it, this article is for you. The stock has had a mixed run recently, with a 4.1% gain over the last 7 days, a 12.7% decline over the past month, a 32.8% decline year to date, a 6.4% gain over the last year, and a very large 3-year return of about 4x. Recent headlines have continued to focus on Affirm's role in the buy now, pay later space, including coverage of its merchant...

MasTec (MTZ) is back on investors’ radar after releasing fourth quarter and full year 2025 results, along with fresh 2026 guidance, combining strong reported growth with ongoing questions around margins and cash generation. See our latest analysis for MasTec. MasTec’s latest earnings and 2026 guidance have come alongside strong price momentum, with a 30 day share price return of 15.8% and a year to date gain of 31.8%. The 1 year total shareholder return of 162.2% and 3 year total shareholder...

If you are wondering whether F.N.B at around US$16.31 is offering fair value or a potential bargain, looking closely at how it is priced against its fundamentals can be a useful next step. The share price has had mixed recent returns, with a 7 day return of a 4.2% decline, a 30 day return of a 13.7% decline, a year to date return of a 5.1% decline, and a 1 year return of 28.5%, a 3 year return of 44.8% and a 5 year return of 49.0%. Recent coverage has focused on F.N.B as a regional bank...

Universal Display (OLED) just extended its long term OLED material supply and license agreements with LG Display, reaffirming a key commercial tie that supports demand for its UniversalPHOLED materials in a crowded OLED market. See our latest analysis for Universal Display. Despite renewing a core agreement with LG Display and recently highlighting progress in white PHOLED lighting, Universal Display’s share price has had a 1 month share price return decline of 20.2% and a 1 year total...

If you are wondering whether Moderna's current share price reflects its true worth, you are not alone. Many investors are asking the same question as the market reassesses the mRNA pioneer. The stock recently closed at US$54.98, with returns of 10.3% over 7 days, 34.1% over 30 days and 78.2% year to date, while the 1 year return is 62.9% and the 3 and 5 year returns are 63.7% and 64.8% declines respectively. Recent headlines have focused on Moderna's mRNA platform and its pipeline beyond...

Why Credicorp’s revised dividend policy matters now Credicorp (NYSE:BAP) has put dividends at the center of the conversation, formally updating its dividend policy and tying future payouts to a detailed set of financial, legal, and solvency conditions. The move comes alongside a series of past and upcoming board meetings focused on dividend distributions and transfers between retained earnings and reserves, which gives investors fresh information on how the company thinks about capital...

Immunome earnings and shelf registration set the stage Immunome (IMNM) has drawn fresh attention after reporting a full year 2025 net loss of US$212.39 million, which was narrower than the prior year, alongside a new shelf registration for up to roughly US$156 million in common stock. See our latest analysis for Immunome. Against this backdrop, Immunome’s share price has been choppy, with a 7.68% 90 day share price return and a 12.14% 30 day share price decline. Yet longer term momentum...

Why Constellium is on investors’ radar today Constellium (NYSE:CSTM) is drawing attention after a strong past 3 months, with the stock showing a 40.5% total return and a 115.3% total return over the past year. For investors tracking industrial materials, that recent performance is prompting a closer look at how Constellium’s $8,449.0 million in revenue and $273.0 million in net income line up with its current share price of $25.49. See our latest analysis for Constellium. At a share price of...

Voyager Technologies (VOYG) just closed FY 2025 with Q4 revenue of US$46.7 million and a basic EPS loss of US$0.52. Trailing 12 month revenue came in at US$166.4 million against a full year EPS loss of US$2.89 and revenue growth of 15.4% over the past year. The company has seen quarterly revenue range from US$34.5 million to US$46.7 million this year, with basic EPS losses stretching from US$0.28 to US$3.45 per quarter. Trailing 12 month net income excluding extra items was a loss of US$116.1...

O-I Glass (OI) recently flagged tougher than expected trading in early 2026, citing softer European demand, temporary supply chain costs from factory closures, and pricing pressure in wine, while still keeping its full year guidance intact. See our latest analysis for O-I Glass. Those softer early 2026 trading conditions and European headwinds help explain why the 30 day share price return sits at a 29.89% decline and the year to date share price return is down 23.09%. At the same time, the 1...